Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Organogenesis Holding (ORGO) Misses Q1 EPS by 6c, Revenues Beat; Offers FY19 Revenue Outlook
May 10, 2019 7:16 AM EDTOrganogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $57.1 million versus the consensus estimate of $52.6 million.
First Quarter 2019 Financial Summary:
Net revenue of $57.1 million for the first quarter of 2019, up 60.8% compared to net revenue of $35.5 million for the first quarter of 2018. Net revenue comprised:Net revenue from Advanced Wound Care products of $47.8 million, up 63.7% from the first quarter of 2018.Net revenue from Surgical & Sports Medicine products of $9.3 million, up 47.2% from the first quarter of... More